Laura Liao

755 total citations
18 papers, 573 citations indexed

About

Laura Liao is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura Liao has authored 18 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura Liao's work include CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Diabetes Management and Research (2 papers). Laura Liao is often cited by papers focused on CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Diabetes Management and Research (2 papers). Laura Liao collaborates with scholars based in United States, United Kingdom and Spain. Laura Liao's co-authors include Hong Lu, Michael E. Rybak, Susan L. Teitelbaum, Robert A. Hiatt, Barbara Brenner, Lawrence H. Kushi, Gayle C. Windham, Antonia M. Calafat, Mary S. Wolff and Susan M. Pinney and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Environmental Health Perspectives.

In The Last Decade

Laura Liao

18 papers receiving 561 citations

Peers

Laura Liao
Jennifer S. Sonderman United States
Yesika Díaz Spain
Zhenni Zhu China
Itsuro Yoshimi Japan
John D. Clark United States
Kyeezu Kim United States
Mehdi Nouraei Iran
Rebecca Tsai United States
Sue Williams United Kingdom
Dian He China
Jennifer S. Sonderman United States
Laura Liao
Citations per year, relative to Laura Liao Laura Liao (= 1×) peers Jennifer S. Sonderman

Countries citing papers authored by Laura Liao

Since Specialization
Citations

This map shows the geographic impact of Laura Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Liao more than expected).

Fields of papers citing papers by Laura Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Liao. The network helps show where Laura Liao may publish in the future.

Co-authorship network of co-authors of Laura Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Liao. A scholar is included among the top collaborators of Laura Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Liao. Laura Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hamadani, Mehdi, Alexander I. Spira, Xiaolei Zhou, et al.. (2023). Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial. Blood Advances. 8(1). 93–98. 5 indexed citations
2.
Chihara, Dai, Laura Liao, Joseph Tkacz, et al.. (2023). Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma. Blood. 142(12). 1047–1055. 45 indexed citations
3.
Hamadani, Mehdi, Lei Chen, Yan Song, et al.. (2022). Matching-adjusted Indirect Comparison of the Efficacy of Loncastuximab Tesirine Versus Treatment in the Chemoimmunotherapy Era for Relapsed/Refractory Diffuse Large B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(8). e738–e744. 6 indexed citations
4.
5.
6.
Hamadani, Mehdi, Laura Liao, T.Y. Yang, Lei Chen, & Craig H. Moskowitz. (2021). Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of Therapies. Clinical Lymphoma Myeloma & Leukemia. 22(6). 373–381. 4 indexed citations
7.
Lodise, Thomas P., et al.. (2021). Hospital Readmissions and Mortality Among Intubated and Mechanically Ventilated Adult Subjects With Pneumonia Due to Gram-Negative Bacteria. Respiratory Care. 66(5). 742–750. 2 indexed citations
8.
Spira, Alexander I., Xiaolei Zhou, Lei Chen, et al.. (2021). Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(3). 158–168. 8 indexed citations
9.
Chen, Lei, Jipan Xie, Aozhou Wu, et al.. (2021). Resource use and costs in patients with relapsed/refractory diffuse large C-cell lymphoma who initiated a third-line therapy in the post CAR-T era: A longitudinal outlook.. Journal of Clinical Oncology. 39(15_suppl). e19560–e19560. 1 indexed citations
10.
Xie, Jipan, Aozhou Wu, Laura Liao, et al.. (2021). Characteristics and treatment patterns of relapsed/refractory diffuse large B-cell lymphoma in patients receiving ≥3 therapy lines in post-CAR-T era. Current Medical Research and Opinion. 37(10). 1789–1798. 10 indexed citations
11.
12.
13.
Mauricio, Dı́dac, Luigi Meneghini, Jochen Seufert, et al.. (2017). Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in E urope and the USA. Diabetes Obesity and Metabolism. 19(8). 1155–1164. 92 indexed citations
14.
Escalada, Javier, Laura Liao, Chunshen Pan, Hongwei Wang, & Mohan Bala. (2016). Outcomes and healthcare resource utilization associated with medically attended hypoglycemia in older patients with type 2 diabetes initiating basal insulin in a US managed care setting. Current Medical Research and Opinion. 32(9). 1557–1565. 8 indexed citations
15.
Hosaka, Akihiro, et al.. (2014). Clinical and Economic Burden in Patients with Diagnosis of Peripheral Arterial Disease in a Claims Database in Japan. Clinical Therapeutics. 36(8). 1223–1230.e4. 7 indexed citations
16.
Jones, Stephen E., Laura Liao, Zhimin Xiao, et al.. (2014). Resource utilization in patients with breast cancer treated with generic versus branded docetaxel.. Journal of Clinical Oncology. 32(15_suppl). 1015–1015. 2 indexed citations
17.
Wolff, Mary S., Susan L. Teitelbaum, Susan M. Pinney, et al.. (2010). Investigation of Relationships between Urinary Biomarkers of Phytoestrogens, Phthalates, and Phenols and Pubertal Stages in Girls. Environmental Health Perspectives. 118(7). 1039–1046. 236 indexed citations
18.
Galvez, Maida P., Hong Lu, Elizabeth Choi, et al.. (2009). Childhood Obesity and Neighborhood Food-Store Availability in an Inner-City Community. Academic Pediatrics. 9(5). 339–343. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer S. Sonderman Breakdown of academic impact, for papers by Yesika Díaz Breakdown of academic impact, for papers by Zhenni Zhu Breakdown of academic impact, for papers by Itsuro Yoshimi Breakdown of academic impact, for papers by John D. Clark Breakdown of academic impact, for papers by Kyeezu Kim Breakdown of academic impact, for papers by Mehdi Nouraei Breakdown of academic impact, for papers by Rebecca Tsai Breakdown of academic impact, for papers by Sue Williams Breakdown of academic impact, for papers by Dian He
Rankless by CCL
2026